Adenocarcinoma and polyposis of the colon in a 20-year-old patient with Trisomy 13: A case report

被引：1
作者：
Thurtle D.P. [1 ]
Huck M.B. [2 ]
Zeller K.A. [1 ]
Jewett T. [1 ]
机构：
[1] Wake Forest School of Medicine, Medical Center Blvd, Winston Salem, 27157, NC
[2] Lehigh Valley Health Network, 1200 S Cedar Crest Blvd, Allentown, 18103, PA
来源：
Journal of Medical Case Reports | / 12卷 / 1期
关键词：
Adenocarcinoma; Colorectal Cancer; Patau syndrome; Polyposis; Trisomy; 13;
D O I：
10.1186/s13256-018-1600-8
中图分类号：
学科分类号：
摘要：
Background: Trisomy 13 is one of the most common autosomal trisomies, and although increasing in number, patients surviving past the neonatal period remain rare. The natural history and expected complications in these patients as they age remains unknown. Despite the rarity of this condition, unusual malignancies have been reported in the medical literature for decades. It is clear that providers should suspect unusual malignancies in these patients, particularly as they age. Case presentation: We report a 20-year-old Caucasian woman with Trisomy 13 who presented with colonic volvulus, found to have colonic polyposis and adenocarcinoma of the colon. Genetics of pathology specimens revealed 47(XX) + 13 without other mutations. She underwent prophylactic completion colectomy due to presumed risk of colorectal cancers given underlying adenomatous polyposis. She has recovered well without evidence of recurrence. Conclusions: The presence of colonic polyposis and colorectal cancer without family history or known mutations for polyposis syndrome suggests an intrinsic predisposition toward colorectal cancer in this patient with Trisomy 13. Recent research into colorectal cancer oncogenes supports that aneuploidy or increased copy number of certain genes on chromosome 13 may increase the risk of malignant transformation. This is an important correlation for researchers studying these topics and clinicians caring for patients with Trisomy 13 as they age. © 2018 The Author(s).
引用
收藏
相关论文
共 22 条
  • [1] Parker S.E., Mai C.T., Canfield M.A., Rickard R., Wang Y., Meyer R.E., Et al., Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006, Birth Defects Res A Clin Mol Teratol, 88, pp. 1008-1016, (2010)
  • [2] Brewer C.M., Survival in trisomy 13 and trisomy 18 cases ascertained from population based registers, J Med Genet, 39, (2002)
  • [3] Meyer R.E., Liu G., Gilboa S.M., Ethen M.K., Aylsworth A.S., Powell C.M., Et al., Survival of children with trisomy 13 and trisomy 18: A multi-state population-based study, Am J Med Genet A, 170, pp. 825-837, (2016)
  • [4] Goldstein H., Nielsen K.G., Rates and survival of individuals with trisomy 13 and 18. Data from a 10-year period in Denmark, Clin Genet, 34, pp. 366-372, (1988)
  • [5] Rasmussen S.A., L-Yc W., Yang Q., May K.M., Friedman J.M., Population-based analyses of mortality in trisomy 13 and trisomy 18, Pediatrics, 111, 4, pp. 777-784, (2003)
  • [6] Satge D., Nishi M., Sirvent N., Vekemans M., Chenard M.-P., Barnes A., A tumor profile in Patau syndrome (trisomy 13), Am J Med Genet A, 173, pp. 2088-2096, (2017)
  • [7] Isaacs H., Congenital and neonatal malignant tumors. A 28-year experience at Children's Hospital of Los Angeles, Am J Pediatr Hematol Oncol, 9, pp. 121-129, (1987)
  • [8] Satge D., Van Den Berghe H., Aspects of the neoplasms observed in patients with constitutional autosomal trisomy, Cancer Genet Cytogenet, 87, pp. 63-70, (1996)
  • [9] Duesberg P., Li R., Multistep carcinogenesis: A chain reaction of aneuploidizations, Cell Cycle, 2, pp. 202-210, (2003)
  • [10] Spirito F.R., Mancini M., Derme V., Cimino G., Testi A.M., Tafuri A., Et al., Trisomy 13 in a patient with common acute lymphoblastic leukemia: Description of a case and review of the literature, Cancer Genet Cytogenet, 144, pp. 69-72, (2003)
123